← Back to headlines
Adicet Bio Secures FDA Clearance for Prostate Cancer Clinical Trial
Gene therapy company Adicet Bio has received regulatory approval from the FDA to proceed with a clinical trial evaluating its experimental treatment for prostate cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Fed Official’s Inflation Remarks Spark Rate Hike Bets and Market Volatility
28m ago
OpenAI Terminates Partnership With AI Tool Cursor Over Contract Violations
1h ago
Meta Agrees to Landmark $17 Billion Settlement Over Teen Safety
2h ago
Former White House Teleprompter Operator Fined for Insider Trading Probe
3h ago